ChemoMetec A/S (CHY) Stock Statistics & Valuation Metrics

ChemoMetec A/S has a market cap or net worth of €1.21B. The enterprise value is ―.

ChemoMetec A/S has 17,402,480 shares outstanding. The number of shares has decreased by -2.65% in one year.

ChemoMetec A/S’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 23.74%.

The current PE Ratio of ChemoMetec A/S is 38.49. ChemoMetec A/S’s PEG ratio is 2.10.

In the last 12 months, ChemoMetec A/S had revenue of 407.87M and earned 136.28M in profits. Earnings per share was 7.83.

In the last 12 months, operating cash flow was 176.20M and capital expenditures -24.04M, giving a free cash flow of 152.17M billion.

ChemoMetec A/S pays an annual dividend of €0.536, resulting in a dividend yield of 0.77%

ChemoMetec A/S upcoming earnings date is Sep 11, 2025, TBA Not Confirmed.

ChemoMetec A/S as a current ratio of 4.97, with Debt / Equity ratio of 1.30%

In the past 12 months, ChemoMetec A/S has paid 40.30M in taxes.

ChemoMetec A/S EV to EBITDA ratio is 26.55, with an EV/FCF ratio of 57.95.

ChemoMetec A/S has €264.74M in cash and marketable securities with kr7.78M in debt, giving a net cash position of -€256.96M billion.

Gross margin is 91.07%, with operating margin of 43.83%, and net profit margin of 33.41%.

The average price target for ChemoMetec A/S is ―, which is 11.43% higher than the current price. The consensus rating is ―